Soritene Cream 0.10% is a topical dermatological medication containing Tazarotene 0.10%, a third-generation synthetic retinoid designed for the treatment of various skin disorders, primarily psoriasis and acne vulgaris. Soritene works by modulating epidermal cell growth, differentiation, and inflammation, helping to normalize the excessive skin cell proliferation that characterizes psoriasis and acne.
Tazarotene is a prodrug that is converted to tazarotenic acid, the active form, which binds selectively to retinoic acid receptors (RAR-β and RAR-γ) in the skin. These receptors regulate gene expression, resulting in reduced keratinocyte proliferation, enhanced differentiation, and decreased inflammation. This makes Soritene Cream highly effective in improving skin appearance, reducing plaques, and controlling lesion formation.
Soritene 0.10% Cream is formulated for topical application, ensuring targeted action with minimal systemic absorption. It is suitable for adult patients requiring potent topical therapy for moderate to severe skin disorders.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Soritene Cream 0.10% is indicated for:
Plaque psoriasis: Reduction of erythema, scaling, and plaque thickness
Acne vulgaris: Treatment of comedonal, papular, and pustular lesions
Other dermatological conditions: Off-label use may include disorders of keratinization under medical supervision
Topical retinoid (Vitamin A derivative)
Mechanism of action: Tazarotene binds selectively to RAR-β and RAR-γ receptors, which control genes regulating keratinocyte proliferation and differentiation.
Effects on skin:
Normalizes abnormal skin cell turnover
Reduces hyperkeratosis and scaling
Minimizes inflammation associated with acne and psoriasis
Pharmacokinetics: Topical application results in minimal systemic absorption, with peak plasma concentrations typically low and transient, reducing systemic side effects.
Adults: Apply a thin layer once daily to the affected area, preferably in the evening
Application tips:
Wash and dry the affected skin before application
Avoid sensitive areas such as eyes, lips, and mucous membranes
Hands should be washed after application to prevent accidental exposure
Use sunscreen and limit sun exposure during treatment, as Tazarotene can increase photosensitivity
Duration of therapy: Improvement may be seen within 2–4 weeks, but continued use is often necessary for optimal results
Pediatric use: Safety and efficacy in children under 12 years have not been established
Hypersensitivity to Tazarotene or any component of the formulation
Pregnancy: Tazarotene is teratogenic and contraindicated in pregnant women (Category X)
Patients with severe skin irritation at the application site
Common adverse effects include:
Local irritation: burning, stinging, redness, dryness, or peeling
Pruritus or mild eczema at the application site
Photosensitivity
Rare but serious effects:
Severe erythema, swelling, or allergic reactions
Exacerbation of psoriasis or dermatitis in sensitive individuals
Pregnancy & Lactation: Tazarotene is highly teratogenic; effective contraception is required for women of childbearing potential
Photosensitivity: Avoid excessive sunlight or UV exposure
Concurrent use: Use caution with other topical irritants (e.g., exfoliants, astringents, or other retinoids)
Monitoring: Regular assessment of skin condition is recommended, especially during the initial weeks of treatment
Store at 15–30°C
Protect from light and moisture
Keep out of reach of children
Tazarotene in Soritene Cream 0.10% modulates epidermal growth and differentiation by binding selectively to retinoic acid receptors. This reduces excessive keratinocyte proliferation, mitigates inflammation, and restores normal skin structure. The targeted topical delivery ensures effective local action with minimal systemic exposure, making it ideal for long-term management of psoriasis and acne.
Login Or Registerto submit your questions to seller
No none asked to seller yet